Drugs and Devices Subcommittee
Drugs and Devices
The Drugs and Devices Subcommittee is dedicated to fostering neurosurgical innovation through strategic partnerships and regulatory expertise. The subcommittee serves as a critical bridge between the specialty and regulatory bodies, strengthening collaboration with the U.S. Food and Drug Administration (FDA) to ensure that neurosurgical interests are represented in the development of medical technology. Central to its mission is educating the neurosurgical community about the complexities of drug and device pathways, equipping members with the knowledge needed to navigate the evolving regulatory landscape.
Joshua M. Rosenow, MD
Chair (term ending in 2026—renewable)
Paul M. Arnold, MD
Vice Chair (term ending in 2026—renewable)
William C. Welch, MD
Past Chair
Owoicho Adogwa, MD, MPH
Council of State Neurosurgical Societies
Rushna P. Ali, MD
Pain Section
Maya A. Babu, MD, MBA
Council of State Neurosurgical Societies
Mark D. Bain, MD
Cerebrovascular Section
Sarah K. Bick, MD
Women in Neurosurgery Section
Kimberly B. Hoang, MD
Tumor Section
Christopher M. Bonfield, MD
Spine Section
Andrew K. Chan, MD, PhD
Spine Section
Isabelle M. Germano, MD, MBA
Tumor Section
Christopher P. Kellner, MD
Cerebrovascular Section
Konstantinos Margetis, MD, PhD
ACS/AANS Health Policy Scholar
Laura Stone McGuire, MD
Women in Neurosurgery Section
Kai J. Miller, MD, PhD
Stereotactic and Functional Section
Richard A. Rammo, MD
Pain Section
Faith C. Robertson, MD, PhD
MBA Resident Fellow
Nathan C. Rowland, MD, PhD
Stereotactic and Functional Section
Uzma Samadani, MD, PHD
Trauma Section
Elizabeth C. Tyler-Kabara, MD, PHD
Pediatric Section
Natalie Torentinos, MPS
AANS/CNS Manager of Regulatory Policy